Press releases
- Hologic Announces Financial Results for Second Quarter of Fiscal 2024
- Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
More ▼
Key statistics
On Friday, Hologic Inc (HOLX:DEU) closed at 70.50, -9.68% below its 52-week high of 78.06, set on May 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 72.00 |
---|---|
High | 73.00 |
Low | 70.00 |
Bid | 71.00 |
Offer | 71.50 |
Previous close | 70.50 |
Average volume | 32.00 |
---|---|
Shares outstanding | 234.73m |
Free float | 233.00m |
P/E (TTM) | 39.37 |
Market cap | 17.97bn USD |
EPS (TTM) | 1.94 USD |
Data delayed at least 15 minutes, as of May 03 2024.
More ▼